BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 29778856)

  • 21. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
    Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.
    Keramida K; Farmakis D; Bingcang J; Sulemane S; Sutherland S; Bingcang RA; Ramachandran K; Tzavara C; Charalampopoulos G; Filippiadis D; Kouris N; Nihoyannopoulos P
    Eur J Heart Fail; 2019 Apr; 21(4):529-535. PubMed ID: 30811091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Cardiotoxic Effects of Carbon Monoxide Poisoning Using Speckle Tracking Echocardiography.
    Saraçoğlu E; Vuruşkan E; Kılıç S; Çekici Y; Onur B; Arslan Y; Kılıç E; Aykut Ö
    Cardiovasc Toxicol; 2018 Apr; 18(2):175-183. PubMed ID: 28986777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.
    Negishi K; Negishi T; Haluska BA; Hare JL; Plana JC; Marwick TH
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):324-31. PubMed ID: 24057661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of Global Longitudinal Strain for Early Identification of Subclinical Left Ventricular Dysfunction in Patients With Active Cancer.
    Laufer-Perl M; Derakhshesh M; Milwidsky A; Mor L; Ravid D; Amrami N; Sherez J; Keren G; Topilsky Y; Arbel Y
    Am J Cardiol; 2018 Nov; 122(10):1784-1789. PubMed ID: 30217373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal Variability of Global Longitudinal Strain in Stable Patients Undergoing Chemotherapy With Trastuzumab.
    Koneru S; Collier P; Goldberg A; Sanghi V; Grimm R; Rodriguez L; Griffin B; Budd T; James K; Popović ZB; Tamarappoo B
    Am J Cardiol; 2016 Sep; 118(6):930-935. PubMed ID: 27553108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
    Kang Y; Xiao F; Chen H; Wang W; Shen L; Zhao H; Shen X; Chen F; He B
    Arq Bras Cardiol; 2018 Mar; 110(3):219-228. PubMed ID: 29694546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.
    Saijo Y; Kusunose K; Okushi Y; Yamada H; Toba H; Sata M
    Heart; 2020 Nov; 106(22):1752-1758. PubMed ID: 32209616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
    Charbonnel C; Convers-Domart R; Rigaudeau S; Taksin AL; Baron N; Lambert J; Ghez S; Georges JL; Farhat H; Lambert J; Rousselot P; Livarek B
    Eur Heart J Cardiovasc Imaging; 2017 Apr; 18(4):392-401. PubMed ID: 28064155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can global longitudinal strain predict reduced left ventricular ejection fraction in daily echocardiographic practice?
    Benyounes N; Lang S; Soulat-Dufour L; Obadia M; Gout O; Chevalier G; Cohen A
    Arch Cardiovasc Dis; 2015 Jan; 108(1):50-6. PubMed ID: 25530159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
    Boyd A; Stoodley P; Richards D; Hui R; Harnett P; Vo K; Marwick T; Thomas L
    PLoS One; 2017; 12(4):e0175544. PubMed ID: 28407011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.
    Zhang KW; Finkelman BS; Gulati G; Narayan HK; Upshaw J; Narayan V; Plappert T; Englefield V; Smith AM; Zhang C; Hundley WG; Ky B
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1059-1068. PubMed ID: 29550306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthracycline induced inconsistent left ventricular segmental systolic function variation in patients with lymphoma detected by three-dimensional speckle tracking imaging.
    Xu Y; Shi J; Zhao R; Zhang C; He Y; Lin J; Zhang Q; Shu X; Cheng L
    Int J Cardiovasc Imaging; 2019 May; 35(5):771-779. PubMed ID: 30684081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
    BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy.
    Anqi Y; Yu Z; Mingjun X; Xiaoli K; Mengmeng L; Fangfang L; Mei Z
    Echocardiography; 2019 Mar; 36(3):495-502. PubMed ID: 30636342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of systolic left ventricular function with speckle-tracking echocardiography in adult patients with repaired aortic coarctation.
    Menting ME; van Grootel RW; van den Bosch AE; Eindhoven JA; McGhie JS; Cuypers JA; Witsenburg M; Helbing WA; Roos-Hesselink JW
    Int J Cardiovasc Imaging; 2016 May; 32(5):777-87. PubMed ID: 26780661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
    Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
    Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and Prognostic Value of Myocardial Work Indices for Identification of Cancer Therapy-Related Cardiotoxicity.
    Calvillo-Argüelles O; Thampinathan B; Somerset E; Shalmon T; Amir E; Steve Fan CP; Moon S; Abdel-Qadir H; Thevakumaran Y; Day J; Woo A; Wintersperger BJ; Marwick TH; Thavendiranathan P
    JACC Cardiovasc Imaging; 2022 Aug; 15(8):1361-1376. PubMed ID: 35926895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of left ventricular global longitudinal strain on speckle echocardiography for predicting chemotherapy-induced cardiotoxicity in breast cancer patients: A systematic review and meta-analysis.
    Li L; Jiang X; Xie Q
    Echocardiography; 2023 Apr; 40(4):306-317. PubMed ID: 36859694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab.
    Bergamini C; Niro L; Springhetti P; Ferri L; Trento L; Minnucci I; Maffeis C; Tafciu E; Rossi A; Fiorio E; Benfari G; Ribichini F
    Cardiovasc Toxicol; 2024 Jun; 24(6):550-562. PubMed ID: 38696070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.